HARRY HILL: Open Payments
NPI 1700033982 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 18 payments from 8 companies in 2025. Trend: 2023 $768 · 2024 $442 · 2025 $762
Food & beverage: $645Education: $117
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $141 |
| Otsuka America Pharmaceutical, Inc. | 2 | $136 |
| Janssen Pharmaceuticals, Inc | 3 | $136 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| E.R. Squibb & Sons, L.L.C. | 5 | $99 |
| Vanda Pharmaceuticals Inc. | 2 | $79 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Alkermes, Inc. | 1 | $20 |
Products named: CAPLYTA, REXULTI, INVEGA SUSTENNA, COBENFY, FANAPT, INGREZZA, LYBALVI.
Industry payments across NY — which companies pay providers there.
